Supplement video ads in San Diego: what you can't say

If you sell supplements out of San Diego, you have probably had an ad rejected for a reason the notice did not explain, rewritten the script, and watched the rewrite get rejected too. The frustrating part is that the line you crossed is usually not the one you think it is. Supplement video ads in San Diego hit this wall more often than most, and the reason has less to do with the platform than with who is writing the script.

Why supplement video ads get flagged more often here

San Diego sits behind only Boston and the Bay Area in life-science concentration, with close to two thousand life-science companies in the region. A lot of the city's supplement brands were founded by people who came out of that ecosystem, or who hire from it. That is a real advantage on formulation and a real liability on paid social.

Science-literate founders write science-literate scripts. The instinct is to lead with the mechanism — the pathway, the bioavailability, the trial the ingredient was tested in. It is the most interesting thing about the product and usually the reason the company exists. It is also the fastest route to a rejected ad, because the moment a script names a mechanism and a benefit in the same breath, a regulator reads it as a health claim, and a health claim carries an evidentiary burden most supplement brands cannot meet.

Brands in thinner markets often write vaguer copy and get away with it by accident. San Diego brands get punished for being precise.

You have to be able to prove what you said

The Federal Trade Commission's health products compliance guidance sets the standard: claims need "competent and reliable scientific evidence", which it defines as tests, analyses, research or studies conducted and evaluated objectively by qualified experts and generally accepted in the profession as yielding accurate results. For health-related benefits specifically, the guidance says substantiation "will need to be in the form of randomized, controlled human clinical testing".

Two things follow from that, and both of them are inconvenient.

The first is that the hook which tests best is very often the one you have the least evidence for. An outcome stated plainly outperforms an ingredient stated plainly, every time. That is not a reason to say it.

The second is that you cannot route a claim through the person on camera to soften it. The guidance is explicit that advertisers "should not make claims through consumer testimonials or expert endorsements that would be deceptive or couldn't be substantiated if the advertiser made them directly", and that it is "not enough that a testimonial represents the honest opinion or experience of an endorser". Nor does a disclaimer rescue it: the guidance says outright that "results not typical" does not cure the deception, and that the standard supplement disclaimer will not fix a misleading ad.

What Meta changed in July

Meta updated its health and wellness advertising standards on 22 July 2026, and the shift is worth understanding because it moves the risk from one part of your ad to another. Enforcement now leans on what the ad claims rather than what it depicts: side-by-side and before-and-after style imagery is no longer disqualifying on sight the way it effectively was.

What stayed prohibited is instructive. Statements of inferiority about someone's physical appearance. Unflattering close-ups — the policy names pinching fat specifically. Claims to cure, heal or eliminate conditions that cannot be cured. Exaggerated or extreme claims used as clickbait. In other words, the imagery rules loosened and the copy rules did not.

If you spent two years avoiding certain shots while writing loose copy, you now have the problem backwards. And passing platform review is not the same as being compliant — Meta's reviewers enforce Meta's policy, not federal advertising law.

The line the person on camera cannot cross

One boundary matters more than any of the above, and it is the one we are most exposed to ourselves. The FTC's rule on consumer reviews and testimonials — 16 CFR Part 465, in force since October 2024 — bans testimonials that misrepresent whose experience they reflect. It covers testimonials generated by AI and testimonials attributed to people who never gave them, and it carries civil penalties per violation.

This is where our own model runs out of road. Every performer in the videos we produce is generated rather than filmed, which means the single highest-converting format in supplements — a real customer describing a real change over a real period of time — is one we cannot make. An AI performer saying "I took this for three months and here is what happened" is not a grey area or an aggressive read of the rule. It is a fabricated testimonial, and we will not script one.

So if a genuine customer account is the centre of your strategy, you need a camera, a real customer and a signed release. That is a legitimate reason to spend money somewhere other than with us. What we are good for is everything around it.

What to open on when you can't open on the claim

The supplement video ads that survive review mostly do it by taking the outcome out of the first two seconds. Do that and you still have plenty to work with. These angles carry no claim at all, and they are the ones worth batching:

• The routine. When in the day, alongside what, and why that timing. A habit is not a health claim.
• The objection. The price, the pill count, the tub that is still three-quarters full from the last brand they tried.
• The label. What is in it and at what dose, read out plainly. Comparing labels is not the same as comparing results.
• The format. How it tastes, whether it dissolves, how big the capsule actually is. Supplements get abandoned over this constantly.
• The situation. Open inside the moment the product is for, not with the product.

Then go through the script and strike three things: anything joining an ingredient to a change in the body, anything putting a timeframe on a result, and anything implying the person speaking experienced an outcome. That last one is the easiest to leave in by mistake, because it usually hides in a verb tense rather than in a sentence you would flag.

Rejections are a tempo problem

The real cost of a rejection is not the ad. It is the week. If you are running three creatives and one gets pulled, your test is dead and you have learned nothing about your audience — only something about a reviewer. If you are running thirty, a rejection is noise you route around.

Volume also lets you find the line empirically. Write the same hook at four different claim heights, run all four, and you learn where review draws the line for your product and category. That is more useful than any policy page, because policy is applied by a mix of automated systems and human reviewers. It is also the practical argument for producing supplement video ads in batches rather than one at a time.

Our plans run $499 a month for twelve videos, $997 for thirty and $1,797 for sixty, and the scripts are AI-written — so a compliant rewrite of a rejected hook is another variant in the batch rather than a fresh quote and a fresh negotiation. Never on your invoice: a percentage of your ad spend. The ads run in your account, which is also where every review decision lands, and that is the right place for it. If you are still working out how many variants you actually need, the arithmetic on testing volume is the same in any category.

Common questions

Can I say a supplement "supports" something instead of "treats" it?

Structure and function language is generally permissible where a disease claim is not, and it is the phrasing most supplement brands land on. It is not a loophole, though: the FTC judges the claim your ad actually communicates to a viewer, not the verb in isolation. Get a lawyer to read your standard script once — it is cheaper than finding out the other way.

Does passing Meta's ad review mean my ad is legal?

No, and this trips up more brands than any policy detail. Platform review checks your ad against platform policy. The FTC's substantiation standard is a separate obligation that applies whether or not an ad was approved, and an approval is not a defence.

Are AI-generated performers allowed in supplement ads?

Platforms permit synthetic media subject to their own disclosure rules, which change, so whoever produces your creative should tell you plainly what was generated. The firmer rule is the one above: never present a synthetic performer as a real customer. What an AI UGC agency actually does covers where that boundary sits in practice.